Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mai A. E. Mourad, Ayman Abo Elmaaty, Islam Zaki, Ahmed A. E. Mourad, Amal Hofni, Ahmed E. Khodir, Esam M. Aboubakr, Ahmed Elkamhawy, Eun Joo Roh & Ahmed A. Al-Karmalawy. (2023) Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2′,3′:4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Wenjing Liu, Min He, Yongjun Li, Zhiyun Peng & Guangcheng Wang. (2022) A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 9-38.
Read now
Read now
Articles from other publishers (21)
Yingjie Cui, Jing Zhang & Guifang Zhang. (2024) The Potential Strategies for Overcoming Multidrug Resistance and
Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer
Therapy. Current Medicinal Chemistry 31:14, pages 1874-1895.
Crossref
Crossref
Sukhmeet Kaur, Jasneet Kaur, Amit Anand, Kirandeep Kaur & Vishal Choudhary. (2024) Chalcones: Effective Agents for Fighting Cancer Across Multiple Cell Lines. ChemistrySelect 9:9.
Crossref
Crossref
Jing Nie, Huina Wu, Yepeng Luan & Jiyong Wu. (2024) The Development of HDAC and Tubulin Dual-Targeting Inhibitors for
Cancer Therapy. Mini-Reviews in Medicinal Chemistry 24:5, pages 480-490.
Crossref
Crossref
Mohammad Mahboubi-Rabbani, Rosa Zarei, Mehdi Baradaran, Maryam Bayanati & Afshin Zarghi. (2024) Chalcones as Potential Cyclooxygenase-2 Inhibitors: A Review. Anti-Cancer Agents in Medicinal Chemistry 24:2, pages 77-95.
Crossref
Crossref
Aliki Drakontaeidi & Eleni Pontiki. (2023) A Review on Molecular Docking on HDAC Isoforms: Novel Tool for Designing Selective Inhibitors. Pharmaceuticals 16:12, pages 1639.
Crossref
Crossref
Reham A. Mohamed-Ezzat, Benson M. Kariuki & Aladdin M. Srour. (2023)
Synthesis, crystal structure and
in vitro
anti-proliferative activity of 2-[(4-acetylphenyl)carbamoyl]phenyl acetate
. Acta Crystallographica Section E Crystallographic Communications 79:11, pages 999-1002.
Crossref
Crossref
Jiahui Yang, Jianmei Lv, Shuxian Cheng, Tingyu Jing, Tenghao Meng, Dezhen Huo, Xin Ma & Ran Wen. (2023) Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry 23:11, pages 1265-1283.
Crossref
Crossref
Vijay K. Patel, Ekta Shirbhate, Priya Tiwari, Rakesh Kore, Ravichandran Veerasamy, Achal Mishra & Harish Rajak. (2023) Multi-targeted HDAC Inhibitors as Anticancer Agents: Current
Status and Future Prospective. Current Medicinal Chemistry 30:24, pages 2762-2795.
Crossref
Crossref
Fernando Ferreira Leite, Natália Ferreira de Sousa, Bruno Hanrry Melo de Oliveira, Gabrielly Diniz Duarte, Maria Denise Leite Ferreira, Marcus Tullius Scotti, José Maria Barbosa Filho, Luís Cezar Rodrigues, Ricardo Olímpio de Moura, Francisco Jaime Bezerra Mendonça-Junior & Luciana Scotti. (2023) Anticancer Activity of Chalcones and Its Derivatives: Review and In Silico Studies. Molecules 28:10, pages 4009.
Crossref
Crossref
Mohammed M. Amin, Gamal El-Din A. Abuo-Rahma, Montaser Sh. A. Shaykoon, Adel A. Marzouk, Mohammed A.S. Abourehab, Roshdy E. Saraya, Mohamed Badr, Ahmed M. Sayed & Eman A.M. Beshr. (2023) Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin/EGFR kinase inhibition. Bioorganic Chemistry 134, pages 106444.
Crossref
Crossref
Amr Ahmed WalyEldeen, Salwa Sabet, Haidan M. El-Shorbagy, Ismail A. Abdelhamid & Sherif Abdelaziz Ibrahim. (2023) Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer. Chemico-Biological Interactions 369, pages 110297.
Crossref
Crossref
Pavithra Palanikarasu, Remya Ramachandran Surajambika & Natarajan Ramalakshmi. (2022) Chalcones and Flavones as Multifunctional Anticancer Agents- A
Comprehensive Review. Current Bioactive Compounds 18:10.
Crossref
Crossref
María Ovejero-Sánchez, Gloria Asensio-Juárez, Myriam González, Pilar Puebla, Miguel Vicente-Manzanares, Rafael Pélaez, Rogelio González-Sarmiento & Ana Belén Herrero. (2022) Panobinostat Synergistically Enhances the Cytotoxicity of Microtubule Destabilizing Drugs in Ovarian Cancer Cells. International Journal of Molecular Sciences 23:21, pages 13019.
Crossref
Crossref
Huajian Zhu, Yuchen Tan, Chen He, Yang Liu, Yiping Duan, Wenjian Zhu, Tiandong Zheng, Dahong Li, Jinyi Xu, Dong-Hua Yang, Zhe-Sheng Chen & Shengtao Xu. (2022) Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects. Journal of Medicinal Chemistry 65:16, pages 11187-11213.
Crossref
Crossref
Tarfah Al-Warhi, Adil Aldhahrani, Fayez Althobaiti, Eman Fayad, Ola A. Abu Ali, Sarah Albogami, Ali H. Abu Almaaty, Amgad I. M. Khedr, Syed Nasir Abbas Bukhari & Islam Zaki. (2022) Design, Synthesis and Cytotoxic Activity Evaluation of Newly Synthesized Amides-Based TMP Moiety as Potential Anticancer Agents over HepG2 Cells. Molecules 27:12, pages 3960.
Crossref
Crossref
Navanath Kumbhar, Snehal Nimal, Sagar Barale, Subodh Kamble, Rohit Bavi, Kailas Sonawane & Rajesh Gacche. (2022) Identification of novel leads as potent inhibitors of HDAC3 using ligand-based pharmacophore modeling and MD simulation. Scientific Reports 12:1.
Crossref
Crossref
Rama Rao Malla, Satyalakshmi Siragam, Vasudha Dadi & Balachandrika Seetini. (2022) Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer. Critical Reviews in Immunology 42:6, pages 27-39.
Crossref
Crossref
Yingge Wang, Moran Sun, Yuyang Wang, Jinling Qin, Yixin Zhang, Yingyue Pang, Yongfang Yao, Hua Yang & Yongtao Duan. (2021) Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency. European Journal of Medicinal Chemistry 225, pages 113790.
Crossref
Crossref
Xiang Qiu, Lv Zhu, Huan Wang, Yan Tan, Zhuang Yang, Linyu Yang & Li Wan. (2021) From natural products to HDAC inhibitors: An overview of drug discovery and design strategy. Bioorganic & Medicinal Chemistry 52, pages 116510.
Crossref
Crossref
Xiaopeng Peng, Jingxuan Chen, Ling Li, Zhiqiang Sun, Jin Liu, Yichang Ren, Junli Huang & Jianjun Chen. (2021) Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents. Journal of Medicinal Chemistry 64:12, pages 8447-8473.
Crossref
Crossref
Yang Ouyang, Juanjuan Li, Xinyue Chen, Xiaoyu Fu, Si Sun & Qi Wu. (2021) Chalcone Derivatives: Role in Anticancer Therapy. Biomolecules 11:6, pages 894.
Crossref
Crossref